Olmesartan Medoxomilo + Hidroclorotiazida Teva (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomilo + Hidroclorotiazida Teva, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with a diuretic, and is suitable for adult patients. GNH USA supplies Olmesartan Medoxomilo + Hidroclorotiazida Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan Medoxomilo + Hidroclorotiazida Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan medoxil combined with hydrochlorothiazide acts on the renin‑angiotensin‑aldosterone system to lower blood pressure.

- Hypertension: provides effective blood‑pressure reduction when monotherapy is insufficient. - Hypertensive heart disease: helps reduce cardiac workload and risk of complications. - Chronic kidney disease with hypertension: assists in slowing progression by controlling systemic pressure.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Dizziness - Headache - Fatigue - Increased urination - Electrolyte imbalance (e.g., low potassium)

Serious or Rare Side Effects: - Angio‑edema - Severe dehydration - Acute kidney injury - Hyperkalemia - Significant drops in blood pressure (hypotension)

Before initiating therapy, consider the following safety measures:

- Renal function: assess baseline kidney function and monitor periodically. - Electrolytes: check serum potassium and sodium levels, especially with diuretic use. - Pregnancy: avoid use in pregnancy due to fetal toxicity. - Concomitant NSAIDs: use caution as they may reduce antihypertensive effect and affect kidney function. - Gout: monitor uric acid, as thiazides can precipitate gout attacks. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Olmesartan medoxil with hydrochlorothiazide may interact with several medicines. Review 

Major Interactions (Avoid): - Potassium‑rich supplements: increase risk of hyperkalemia. - ACE inhibitors or ARBs combined: may cause excessive potassium elevation. - Lithium: can raise lithium levels, risking toxicity.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihyhydrohyd  - Diuretics other than hydrochlorothiazide: additive electrolyte disturbances. - Antifungal  - Alcohol